By Rodney Herbert Prostate cancer is often slow-growing, and many men do not need immediate treatment. Instead, doctors may suggest monitoring the cancer over time. Two main monitoring strategies are Active Surveillance and Watchful Waiting. While they sound similar, they have important differences in approach, follow-up, and goals. Below, we compare and contrast these [...]
By Rodney Herbert Prostate cancer screening often starts with a PSA blood test. PSA stands for prostate-specific antigen, a protein made by the prostate gland. Doctors look not just at the PSA number itself, but also at PSA velocity (how fast PSA changes over time) and PSA density (PSA level relative to prostate size) [...]
By Rodney Herbert Prostate cancer screening often uses a blood test called PSA (prostate-specific antigen). For many years, doctors followed a simple rule: if a man's PSA was above 4.0, it was a red flag, and if it was below 4.0, it was considered normal. Today we know it’s not that simple. In this [...]
Prostate-specific antigen (PSA) tests can be confusing, especially when doctors start talking about “free PSA” and “total PSA.” This guide will break down what PSA is, explain the difference between free and total PSA in simple terms, and why these tests matter for prostate cancer screening and diagnosis. What is PSA? PSA stands for [...]
By Rodney Herbert Early detection of prostate cancer is very important. However, traditional methods like the PSA blood test and random biopsies can sometimes miss aggressive cancers or find slow-growing cancers that might never cause harm. Multiparametric MRI (mpMRI) is a newer imaging tool that is changing this. It helps doctors find dangerous prostate [...]